GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
By
Ed Cara
A five-star bake. Worth schmearing, sharing, saving.
Summary
New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As prescription rates for these drugs have skyrocketed in the U.S., there has been a modest but sustained drop in obesity rates, suggesting the medications may finally be turning the tide against the obesity epidemic at a population level.
Key quotes
· 3 pulledThe prescription rate of GLP-1 drugs in the U.S. has skyrocketed in recent years, the data shows, coinciding with a modest but sustained drop in the obesity rate.
New data seems to show that GLP-1 medications like semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, are working on a population-wide level.
Though it's still too early to tell, the long-term and widespread use of GLP-1s could finally start to [turn the tide against obesity].
You might also wanna read
Study: Ozempic and Wegovy Reduce Household Food Spending and Change Purchasing Patterns
New research published in the Journal of Marketing Research shows that GLP-1 receptor agonist drugs like Ozempic and Wegovy are significantl
news.cornell.edu·4mo ago
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
A study analyzing over 6,800 colon cancer patients across University of California Health sites found that patients taking GLP-1 medications
What Happens When You Stop Taking GLP-1 Weight Loss Medications
This article examines the experiences of people who stop taking GLP-1 weight loss medications (like Ozempic and Wegovy), exploring what happ
bbc.com·5mo ago
Weight-Loss Drugs Like Ozempic Shift Societal Attitudes on Body Image and Weight Loss
The article discusses how weight-loss drugs like Ozempic are changing societal attitudes toward body image and weight loss. It presents a ca
wsj.com·4mo ago
Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections
Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight loss drug Wegovy in the US at a significantly lower price t
theguardian.com·4mo ago
GLP-1 Medications Show Promise for Treating Addiction Through Brain Reward Pathways
The article explores the emerging potential of GLP-1 medications like Ozempic to treat various addictions beyond their original diabetes and
newyorker.com·3mo ago